SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zebra 365 who wrote (5374)2/12/1998 11:34:00 AM
From: Zebra 365  Read Replies (2) of 23519
 
New VVUS Primary Care Promotion

Just received today, another Yellow Package from VVUS. Inside, a patient education package with pamphlet, video and algorithm for titration of MUSE.

Also, for the doc, an outline of applicable CPT and ICD-9 codes for reimbursement for titration of MUSE therapy. Even suggests that many state Medicaid programs are reimbursing for it.

A nice laminated 4-color card with the algorithm for titration, it really suggests titration starting at the 250mcg dose, (instead of the 125mcg), with a comment that 90% of patients in clinical trials selected a dose of 250mcg or higher.

You may recall my speculation earlier that, from what I was hearing from urologists in practice, a lot of the non-refills and unsold product in the channel were the 125mcg and the 250mcg doses. This package tends to reinforce that perception.

This is directed toward the PCP, offers more complimentary education kits, educational brochures (on request, saves sending out a lot of videos to be trashed). Two brochures: "Restore the Feeling" and "Understanding Erectile Dysfunction"

All very well done. I'm starting to do this in my practice, so far only a handfull of patients, but inquiries are increasing. I won't report my results here, because this is not a clinical study and will never have enough patients to reach statistical significance. The one point I will make, I have not seen any significant adverse side-effects at this point that would make me reconsider offering this service.

Zebra
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext